Tolterodine Tartrate
Showing 26 - 50 of 228
Ocular Redness Trial in United States (Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation, Lumify®
Recruiting
- Ocular Redness
- Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
- Lumify® (brimonidine tartrate ophthalmic solution 0.025%)
-
Colorado Springs, Colorado
- +5 more
Oct 3, 2022
Overactive Bladder Trial (tolterodine tartrate, Comparator: Placebo to tolterodine tartrate)
Completed
- Overactive Bladder
- tolterodine tartrate
- Comparator: Placebo to tolterodine tartrate
- (no location specified)
Jan 24, 2018
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Overactive Bladder, Benign Prostatic Hyperplasia Trial in Seoul (doxazosin plus tolterodine SR)
Completed
- Overactive Bladder
- Benign Prostatic Hyperplasia
- doxazosin plus tolterodine SR
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 28, 2019
Spinal Vascular Disorder Nos, Overactive Bladder Trial (surgery, sacral neuromodulation, botulinum toxin A injection)
Not yet recruiting
- Spinal Vascular Disorder Nos
- Overactive Bladder
- surgery
- +3 more
- (no location specified)
Apr 28, 2020
Healthy Trial in Basel (Lysergic Acid Diethylamide Base oral drinking solution, Lysergic Acid Diethylamide Base solid
Recruiting
- Healthy
- Lysergic Acid Diethylamide Base oral drinking solution
- +4 more
-
Basel, SwitzerlandClinical Pharmacology & Toxicology, University Hospital Basel
Mar 30, 2022
COVID-19 Virus Infection Trial in Salvador (LCLT : 68% elemental L-carnitine and 32 % Tartric acid, Placebo)
Completed
- COVID-19 Virus Infection
- LCLT : 68% elemental L-carnitine and 32 % Tartric acid
- Placebo
-
Salvador, Bahia, BrazilSenai Cimatec
Jun 30, 2022
Dry Eye Trial in United States (Brimonidine Tartrate, Placebos)
Completed
- Dry Eye
- Brimonidine Tartrate
- Placebos
-
Newport Beach, California
- +15 more
Jun 29, 2022
Helicobacter Pylori Infection Trial in Changsha (Group1 Vonoprazan Fumarate + amoxicillin + doxycycline, Group2 Vonoprazan
Recruiting
- Helicobacter Pylori Infection
- Group1 Vonoprazan Fumarate + amoxicillin + doxycycline
- +3 more
-
Changsha, Hunan, ChinaThe third Xiangya Hospital of central south University
Feb 2, 2022
Overactive Bladder (OAB) Trial in Canada, United States (Mirabegron, Tolterodine ER)
Completed
- Overactive Bladder (OAB)
- Mirabegron
- Tolterodine ER
-
Homewood, Alabama
- +29 more
Feb 17, 2020
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Brimonidine Tartrate Ophthalmic Suspension
- Brimonidine Tartrate Ophthalmic Solution
-
Chandler, Arizona
- +46 more
Jan 27, 2022
Healthy Trial in Ciudad de México (Tirfostina/L-Carnitina)
Enrolling by invitation
- Healthy
- Tirfostina/L-Carnitina
-
Ciudad de México, Azcapotzalco, MexicoPharmet, S.A de C.V.
Aug 2, 2022
Alzheimer, Parkinson Disease Trial in Antalya, Istanbul (Metabolic Cofactor Supplementation, Sorbitol)
Completed
- Alzheimer Disease
- Parkinson Disease
- Metabolic Cofactor Supplementation
- Sorbitol
-
Antalya, Turkey
- +1 more
Aug 5, 2022
Overactive Bladder Trial in United States (Tolterodine tartrate extended release capsules, Desmopressin orally disintegrating
Completed
- Overactive Bladder
- Tolterodine tartrate extended release capsules
- +2 more
-
Jonesboro, Arkansas
- +23 more
Aug 16, 2018
Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic
Not yet recruiting
- Seasonal Allergic Conjunctivitis
- Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
- +3 more
-
Andover, Massachusetts
- +1 more
Nov 9, 2022
Anxiety Generalized Trial in Lauderhill (MM-120, Placebo)
Recruiting
- Anxiety Generalized
- MM-120 (LSD D-Tartrate)
- Placebo
-
Little Rock, Arkansas
- +15 more
Jan 27, 2023
Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics Trial in Seoul (Mirabegron
Active, not recruiting
- Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics
- Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Gut Health, Metabolism, Weight Loss Trial in Santa Monica (Colon Broom Premium supplement)
Active, not recruiting
- Gut Health
- +3 more
- Colon Broom Premium supplement
-
Santa Monica, CaliforniaCitruslabs
Aug 28, 2023
Overactive Bladder in Taiwan, Korea and China
Completed
- Overactive Bladder (OAB)
- mirabegron
- +8 more
-
Daejeon, Korea, Republic of
- +14 more
Apr 21, 2020
Premature Ventricular Contraction Trial (Tongmai Yangxin Pill (TMYXP), metoprolol tartrate, )
Completed
- Premature Ventricular Contraction
- Tongmai Yangxin Pill (TMYXP)
- +2 more
- (no location specified)
Aug 9, 2021
Glaucoma, Glaucoma, Open-Angle, Glaucoma; Drugs Trial in New Orleans (brimonidine tartrate ophthalmic solution 0.025%, sterile
Not yet recruiting
- Glaucoma
- +5 more
- brimonidine tartrate ophthalmic solution 0.025%
- sterile balanced saline solution
-
New Orleans, LouisianaTulane University Medical Center
Apr 4, 2022
Peritoneal Dialysis Trial (Melatonin, )
Not yet recruiting
- Peritoneal Dialysis
- Melatonin
- placebo
- (no location specified)
Oct 21, 2023
Cesarean Section Complications, Spinal Anesthesia Trial in Orléans (Norepinephrine, Phenylephrine)
Completed
- Cesarean Section Complications
- Spinal Anesthesia
-
Orléans, FranceRegional Hospital Center of ORLEANS
May 26, 2021